2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual

Partnering Events:

TechConnect Summit
Clean Technology 2008

A new target and compounds for treating age-related macular degeneration

L. Provencher
Univalor, CA

blindness, age-related macular degeneration, new chemical entities, CD36, new target

The technology is a unique class of selective CD36 modulators that are novel drug candidates for treating age-related macular degeneration (AMD). Besides being the first class of specific CD36 modulator, the technology introduces a new approach for treating AMD by aiming at a new biological target.

Nanotech 2008 Conference Program Abstract